Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-23T20:53:18.575Z Has data issue: false hasContentIssue false
  • English
  • Français

SARS-CoV-2 and RT-PCR Testing in Travelers: Results of a Cross-sectional Study of Travelers at Iraq’s International Borders

Published online by Cambridge University Press:  08 June 2022

Doaa Abdulkhaleq Salih ,
Jivan Qasim Ahmed ,
Marwan Khalil Qader ,
Mohammed S. Shukur ,
Bayar K. A. Zeebaree ,
Mateen Bahjat Sadeq ,
Sirwan Najeeb Mohammed ,
Hushank Nadhmi Masiha ,
Ibrahim Mohammed Abdullah  and
Omar Mohammed
...Show all authors
Doaa Abdulkhaleq Salih*
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Directorate General of Health, Kurdistan Region of Iraq
Jivan Qasim Ahmed
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Department of pathology and Microbiology, University of Duhok, Kurdistan Region, Iraq
Marwan Khalil Qader
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center College of Science, University of Duhok, Kurdistan Region, Iraq
Mohammed S. Shukur
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Department of surgery and medicine, University of Duhok, Kurdistan Region, Iraq
Bayar K. A. Zeebaree
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Department of surgery and medicine, University of Duhok, Kurdistan Region, Iraq
Mateen Bahjat Sadeq
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Zanist Family Medicine Centre, Directorate General of Health, Kurdistan Region of Iraq
Sirwan Najeeb Mohammed
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center
Hushank Nadhmi Masiha
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center
Ibrahim Mohammed Abdullah
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Medical Lab Technology Department, College of Health and Medical Technology-Shekhan, Duhok Polytechnic University, Iraq
Omar Mohammed
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Preventive Health Affairs Directorate, Directorate General of Health, Kurdistan Region of Iraq
Luqman Saleh Taha
Affiliation:
Duhok Central Public Health Laboratory, Duhok, Kurdistan Region of Iraq
Rawand Al-Qadi
Affiliation:
Ibrahim Al-Khalil Border Crossing Coronavirus Testing Center Duhok Central Public Health Laboratory, Duhok, Kurdistan Region of Iraq
*
Corresponding author: Doaa Abdulkhaleq Salih, Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

In late 2019, a novel coronavirus was detected in Wuhan, China, that caused a pandemic by September 2021, resulting in 224,180,411 cases and more than 4,600,000 deaths worldwide. In response to the pandemic, the Autonomous Kurdistan Regional Government of Iraq (KRG) imposed strict infection control measures at its borders for all travelers from neighboring countries, wherein each traveler was subjected to a mandatory reverse transcription polymerase chain reaction (RT-PCR) test on arrival to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected travelers. The aim of this study is to determine the rate of infection with SARS-CoV-2 among the travelers entering Kurdistan region through Ibrahim Al-Khalil crossing point with Turkey as a predictor for the upcoming infection waves.

Methods:

The data of RT-PCR tests to detect SARS-CoV-2 in all travelers arriving at the Ibrahim Al-Khalil Border Crossing between Iraq and the Republic of Turkey were reviewed from August 21, 2020 to August 21, 2021.

Results:

It was found that there were 9873 cases of SARS-CoV-2 infections among 1,082,074 travelers during the study period.

Conclusions:

This study shows the importance of mass testing of travelers at border crossings to control the spread of SARS-CoV-2 infection.

Type
Brief Report
Information
Disaster Medicine and Public Health Preparedness , Volume 16 , Issue 6 , December 2022 , pp. 2422 - 2424
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sun, Y, Dong, Y, Wang, L, et al. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020;112:102473. doi: 10.1016/j.jaut.2020.102473 CrossRefGoogle ScholarPubMed
BBC. Covid-19 vaccine: first person receives Pfizer jab in UK. 2020. Accessed June 15, 2022. https://www.bbc.com/news/uk-55227325 Google Scholar
Wang, H, Li, X, Li, T, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629-1635. doi: 10.1007/s10096-020-03899-4 Google ScholarPubMed
Ahmad, JQ, Tayib, GA, Mohamed, T. SARS-CoV-2 mutation hotspots incidence in different geographic regions. Microbiol Syst. 2020;5(2):1-8.Google Scholar
WHO. Novel Coronavirus (2019-nCoV): situation report, 19. Accessed June 15, 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ Google Scholar
Van Vinh Chau, N, Lam, VT, Dung, NT, et al. The natural history and transmission potential of asymptomatic severe acute respiratory syndrome coronavirus 2 infection. Clin Infect Dis. 2020;71(10):2679-2687. doi: 10.1093/cid/ciaa711 CrossRefGoogle ScholarPubMed
gov.krd. Dashboard. Coronavirus (COVID-19). Accessed June 15, 2022. https://gov.krd/coronavirus-en/dashboard/ Google Scholar
Hur, KH, Park, K, Lim, Y, et al. Evaluation of four commercial kits for SARS-CoV-2 real-time reverse-transcription polymerase chain reaction approved by emergency-use-authorization in Korea. Front Med (Lausanne). 2020;7:521. doi: 10.3389/fmed.2020.00521 CrossRefGoogle ScholarPubMed
Claas, ECJ, Smit, PW, van Bussel, MJAWM, et al. A two minute liquid based sample preparation for rapid SARS-CoV2 real-time PCR screening: a multicentre evaluation. J Clin Virol. 2021;135:104720. doi: 10.1016/j.jcv.2020.104720 CrossRefGoogle ScholarPubMed
Lohse, S, Pfuhl, T, Berkó-Göttel, B, et al. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect Dis. 2020;20(11):1231-1232. doi: 10.1016/s1473-3099(20)30362-5 Google ScholarPubMed
Garg, J, Singh, V, Pandey, P, et al. Evaluation of sample pooling for diagnosis of COVID-19 by real time-PCR: a resource-saving combat strategy. J Med Virol. 2021;93(3):1526-1531. doi: 10.1002/jmv.26475 CrossRefGoogle ScholarPubMed
Hanel, R, Thurner, S. Boosting test-efficiency by pooled testing for SARS-CoV-2-Formula for optimal pool size. PLoS One. 2020;15(11):e0240652. doi: 10.1371/journal.pone.0240652 CrossRefGoogle ScholarPubMed
Perchetti, GA, Sullivan, KW, Pepper, G, et al. Pooling of SARS-CoV-2 samples to increase molecular testing throughput. J Clin Virol. 2020;131:104570. doi: 10.1016/j.jcv.2020.104570 CrossRefGoogle ScholarPubMed
Regen, F, Eren, N, Heuser, I, et al. A simple approach to optimum pool size for pooled SARS-CoV-2 testing. Int J Infect Dis. 2020;100:324-326. doi: 10.1016/j.ijid.2020.08.063 Google ScholarPubMed
Bielecki, M, Crameri, GAG, Schlagenhauf, P, et al. Body temperature screening to identify SARS-CoV-2 infected young adult travellers is ineffective. Travel Med Infect Dis. 2020;37:101832. doi: 10.1016/j.tmaid.2020.101832 Google ScholarPubMed
Ritchie, H, Mathieu, E, Rodés-Guirao, L, et al. Coronavirus pandemic (COVID-19). OurWorldInData.org. Accessed June 16, 2022. https://ourworldindata.org/coronavirus Google Scholar
Becker, M, Dulovic, A, Junker, D, et al. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals. Nat Commun. 2021;12(1):3109. doi: 10.1038/s41467-021-23473-6 CrossRefGoogle ScholarPubMed